Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tango Therapeutics
Tango Therapeutics
Eliem cuts in on Tango, proposing acquisition after strategic review
Fierce Biotech
Tue, 03/19/24 - 11:51 am
Eliem Therapeutics
Tango Therapeutics
M&A
oncology
Why Shares of Tango Therapeutics Climbed This Week
Motley Fool
Thu, 09/14/23 - 10:56 pm
Tango Therapeutics
CRISPR
gene editing
clinical trials
It takes two to Tango: The biotech using CRISPR to discover new cancer gene targets rides a $353M SPAC deal to Nasdaq
Endpoints
Wed, 04/14/21 - 10:02 am
Tango Therapeutics
SPAC
NASDAQ
Gilead expands Tango alliance, continuing a busy year of cancer deals
Biopharma Dive
Tue, 08/18/20 - 10:53 pm
Gilead Sciences
Tango Therapeutics
oncology
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs
Xconomy
Thu, 04/9/20 - 10:28 am
Tango Therapeutics
CRISPR
cancer
drug development
Gilead Sciences and Tango Therapeutics Form Partnership Worth Up to $1.7 Billion to Develop Next-Gen Immuno-Oncology Therapies
CP Wire
Wed, 10/31/18 - 12:02 pm
Gilead Sciences
Tango Therapeutics
cancer immunotherapy
Gilead Sciences and Tango Therapeutics Form Partnership Worth Up to $1.7 Billion to Develop Next-Gen Immuno-Oncology Therapies
Wed, 10/31/18 - 12:00 pm
Gilead Sciences
Tango Therapeutics
cancer immunotherapy
